| |
Survivor
|
No- Survivor
|
p-value
|
|---|
|
Age
|
43.9 ± 16.7
|
45.8 ± 16.8
|
0.638
|
|
Sex(M:F)
|
22/17
|
23/9
|
0.220
|
|
BMI
|
23.1 ± 3.4
|
24.1 ± 3.5
|
0.227
|
|
Comorbidities, n (%)
|
|
Coronary artery disease
|
1 (2.6)
|
1 (3.1)
|
> 0.999
|
|
Hypertension
|
5 (12.8)
|
8 (25.0)
|
0.227
|
|
Diabetes Mellitus
|
3 (7.7)
|
7 (21.9)
|
0.168
|
|
Lung disease
|
1 (2.6)
|
2 (6.3)
|
0.585
|
|
Previous Arrhythmia
|
0 (0.00)
|
2 (6.3)
|
0.200
|
|
Tumour
|
3 (7.7)
|
2 (6.3)
|
> 0.999
|
|
Autoimmune disease
|
3 (7.7)
|
0 (0.00)
|
0.247
|
|
Smoking
|
10 (25.6)
|
11 (34.4)
|
0.446
|
|
Alcohol
|
9 (23.1)
|
5 (15.6)
|
0.553
|
|
APACHE II
|
24.0 [19.0, 31.5]
|
34.50 [28.3, 36.0]
|
0.002
|
|
Protopathy
| | |
0.003
|
|
FMC
|
24 (61.5)
|
7 (21.9)
| |
|
AMI
|
10 (25.6)
|
12 (37.5)
| |
|
SACM
|
2 (5.1)
|
3 (9.4)
| |
|
OCCA
|
3 (7.7)
|
10 (31.3)
| |
|
Reason of ECMO
| | |
0.002
|
|
RSC
|
26 (66.7)
|
9 (28.1)
| |
|
CA
|
13 (33.3)
|
23 (71.9)
| |
|
Complications
|
|
Bleeding
|
3 (7.7)
|
16 (50.0)
|
< 0.001
|
|
CRBSI
|
0 (0.0)
|
3 (9.4)
|
0.087
|
|
ECMO support time
|
131.0 [116.0, 178.0]
|
168.5 [124.3, 219.3]
|
0.047
|
|
tIPPaO2
|
30.0 [17.5, 50.0]
|
92.00 [48.8, 148.5]
|
< 0.001
|
|
ICU time
|
17.0 [15.0, 24.5]
|
9.0 [7.0, 13.3]
|
< 0.001
|
|
length of stay
|
20.0 [17.5, 30.0]
|
9.00 [7.0, 13.3]
|
< 0.001
|
|
CRRT time
|
0.0 [0.0, 5.0]
|
6.0 [3.0, 8.3]
|
0.001
|
|
MV time
|
7.0 [5.0, 9.0]
|
9.00 [7.0, 12.3]
|
0.022
|
|
Platelet
|
69.5 [50.3, 93.0]
|
31.0 [22.8, 42.3]
|
< 0.001
|
- BMI body mass index, APACHE acute physiology and chronic health evaluation, FMC fulminant myocarditis, AMI acute myocardial infarction, SACM sepsis-associated cardiomyopathy, OCCA other causes related cardiac arrest, RSC refractory cardiogenic shock, CA cardiac arrest, CRBSI catheter-related blood stream infection, tIPPaO2 time of inflection point of arterial oxygen partial pressure, ICU intensive care unit, CRRT continuous renal replacement therapy and MV mechanical ventilation
